Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: A prospective, multicenter, European study

Annals of Surgery

Volumn 253, Issue 4, 2011, Pages 711-719

  Taylor, Fiona G M ^a   Quirke, Philip ^b   Heald, Richard J ^c   Moran, Brendan ^c   Blomqvist, Lennart ^d   Swift, Ian ^a   Sebag Montefiore, David J ^e   Tekkis, Paris ^f   Brown, Gina ^f,g  

^a MAYDAY UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^f INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^g ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROPYRIDINE; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECTUM CANCER; REPRODUCIBILITY; SURGICAL TECHNIQUE; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; COLECTOMY; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OBSERVER VARIATION; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; RECTUM; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79953188304     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31820b8d52     Document Type: Article

References (36)

1. Diaz-Gonzalez JA, Arbea L, Aristu J. Rectal cancer treatment: improving the picture. World J Gastroenterol. 2007;13(44):5805-5812. (Pubitemid 350148497)
2. Carne PW, Nelson H. Are we overtreating rectal cancer: time for another trial? Ann Surg Oncol. 2004;11(2):124-126.
3. Pahlman L. Indications for neoadjuvant long-term radiotherapy: recent results in cancer research. Fortschritte der Krebsforschung. 2005;165:212-220.
4. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990;264(11):1444-1450.
5. O'Connell MJ, Martenson JA, Wieand HS, et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med. 1994;331(8):502-507.
6. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med. 1991;324(11):709-715.
7. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17): 1731-1740.
8. Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patientswith rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373(9666):811-820.
9. Peeters KC, Marijnen CA, Nagtegaal ID, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007;246(5):693-701. (Pubitemid 350035641)
10. Gunderson LL, Sargent DJ, Tepper JE, et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol. 2004;22(10):1785-1796. (Pubitemid 41095168)
11. MERCURY. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ. 2006;333(7572):779.
12. MERCURY. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology. 2007;243(1):132-139.
13. Hermanek P, Junginger T. The circumferential resection margin in rectal carcinoma surgery. Techn Coloproctol. 2005;9(3):193-199; discussion 9-200. (Pubitemid 41772330)
14. Hermanek P, Guggenmoos-Holzmann I, Gall FP. Prognostic factors in rectal carcinoma: a contribution to the further development of tumor classification. Dis Colon Rectum. 1989;32(7):593-599.
15. Smith NJ, Barbachano Y, Norman AR, et al. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg. 2008;95(2):229-236.
16. Willett CG, Badizadegan K, Ancukiewicz M,et al. Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy? Dis Colon Rectum. 1999;42(2):167-173. (Pubitemid 29085151)
17. Willett CG, Czito BG, Bendell JC. Radiation therapy in stage II and III rectal cancer. Clin Cancer Res. 2007,15;13(22 pt 2):6903s-6908s. (Pubitemid 350206837)
18. Merkel S, Mansmann U, Siassi M, et al. The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis. 2001;16(5):298-304. (Pubitemid 32927002)
19. Cawthorn SJ, Parums DV, Gibbs NM, et al. Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet. 1990;335(8697):1055-1059. (Pubitemid 20148648)
20. Salerno GV, Daniels IR, Moran BJ, et al. Magnetic resonance imaging prediction of an involved surgical resection margin in low rectal cancer. Dis Colon Rectum. 2009;52(4):632-639.
21. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1(8496):1479-1482. (Pubitemid 16095660)
22. Quirke P, Durdey P, DixonMF, et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2(8514):996-999. (Pubitemid 16005611)
23. Donner A, Eliasziw M. A goodness-of-fit approach to inference procedures for the kappa statistic: confidence interval construction, significance testing and sample size estimation. Stat Med. 1992;11:1511-1519.
24. Pahlman L, Glimelius B. The value of adjuvant radio(chemo)therapy for rectal cancer. Eur J Cancer. 1995;31A(7-8):1347-1350.
25. Jessop J, Beagley C, Heald RJ. The Pelican Cancer Foundation and The English National MDT-TME Development Programme. Colorectal Dis. 2006;8 (suppl 3):1-2.
26. What is the Government doing to improve outcomes for patients with bowel cancer? Colorect Dis. 2004;6(6):521-524.
27. Kapiteijn E, Putter H, van de Velde CJ. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg. 2002;89(9):1142-1149. (Pubitemid 34989221)
28. Burton S, Brown G, Daniels IR, et al. MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins? Br J Cancer. 2006;94(3):351-357. (Pubitemid 43237559)
29. Martling AL, Holm T, Rutqvist LE, et al. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet. 2000;356(9224):93-96. (Pubitemid 30438509)
30. Pahlman L, Laurberg S, Soreide O. Structuring rectal cancer treatment in Scandinavia. Surg Oncol Clin N Am. 2001;10(4):855-862, x. (Pubitemid 33070748)
31. Gunderson LL, Callister M, Marschke R, et al. Stratification of rectal cancer stage for selection of postoperative chemoradiotherapy: current status. Gastrointest Cancer Res. 2008;2(1):25-33.
32. Marijnen CA, van de Velde CJ. Preoperative radiotherapy for rectal cancer. Br J Surg. 2001;88(12):1556-1557. (Pubitemid 33124228)
33. Chua YJ, Barbachano Y, Cunningham D, et al. Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRIdefined poor-risk rectal cancer: a phase 2 trial. Lancet Oncol. 2010;11(3): 241-248.
34. Gunderson LL, Sargent DJ, Tepper JE, et al. Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysis. Int J Rad Oncol, Biol, Phys. 2002;54(2):386-396. (Pubitemid 35286802)
35. Improved survival with preoperative radiotherapy in resectable rectal cancer: Swedish Rectal Cancer Trial. N Engl J Med. 1997;336(14): 980-987.
36. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638-646.